Full Length Research Paper
References
Abebe A, Nokes J, Dejene A, Enquselassie F, Messele T, Cutts FT (2003). Sero epidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol. Infect. 131: 757-770. Crossref |
||||
Alter M (2006). Epidemiology of hepatitis virus and HIV co-infection. J. Hepatol. 44:56-59. Crossref |
||||
Awole M, Gebre SS (2005). Seroprevalence of HBsAg and its risk factors among pregnant women in Jimma, Southwest Ethiopia. Ethiop. J. Health Dev. 19:45-50. Crossref |
||||
BoFED (2009). The population report of Amhara region by zone: Reports for North ShoaZone. Amhara National Regional State Bureau of Finance and Economic Development, Bahirdar. | ||||
Burnett RJ, Francois G, Kew M (2005). Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int. 25:201-24. Crossref |
||||
Chang JJ, Wightman F, Bartholomeusz A (2005). Reduced hepatitis B virus (HBV)-specific CD4-T-cell responses in Human Immunodeficiency Virus type 1-HBV- co infected individuals receiving HBV-active antiretroviral therapy. J. Virol. 79(5):3038-3051. Crossref |
||||
Crane M, Sirivichayakul S, Chang JJ (2010). No increase in hepatitis B virus (HBV) specific CD8-T cells in patients with HIV-1-HBV co-infections following HBV-active HAART. J. Virol. 84(6):2657-2665. Crossref |
||||
Datiko DG, Yassin MA, Chekol LT, Kabeto LE, Lindtjorn B (2008). The rate of TB-HIV co-infection depends on the prevalence of HIV infection in a community. BMC Public Health 8:266. Crossref |
||||
Duncan M, Tibaus G, Pelzer A (1995). Prevalence and significance of sexually transmitted diseases among women attending clinics in Addis Ababa. Ethiop. J. Health Dev. 9:31-40. | ||||
Easterbrook P, Sands A, Harmanci H (2013). Challenges and priorities in the management of HIV/HBV and HIV/HCV co-infection in resource-limited areas. Semin. Liver Dis. 32:147-157. | ||||
Hoffmann CJ, Thio CL (2007). Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect. Dis. 7(6):402-409. Crossref |
||||
Kenneth S, Marion P, Margaret K (2007). HIV and Liver Disease Forum: Conference Proceedings. Hepatology 45:1566-1577. Crossref |
||||
Kim HN, Scott J, Cent A, Cook L, Morrow RA, Richardson B, Tapia K, Jerome KR, Lule G, John-Stewart G, Chung MH (2011). HBV lamivudine resistance among hepatitis B and HIV co-infected patients starting lamivudine, stavudine and nevirapine in Kenya. J. Viral Hepat. 18:e447-e452. Crossref |
||||
Lacombe K, Bottero J, Lemoine M, Boyd A, Girard PM (2010). HIV/HBV co-infection: current challenges and new strategies. J. Antimicrob. Chemother. 65:10-17. Crossref |
||||
Lacombe K, Rockstroh J (2012). HIV and viral hepatitis co-infections: advances and challenges. Gut:i47-i48 Crossref |
||||
Levy V, Robert M (2006). Antiretroviral therapy for hepatitis B virus-HIV co-infected patients: promises and pitfalls. Clin. Infect. Dis. 43:904-910. Crossref |
||||
Martinez E, Blanco G, Arnaiz A (2001). Hepatotoxicity in HIV1 infected patients receiving nevirapine-containing antiretroviral therapy. AIDS 15:1261-8. Crossref |
||||
Mascolini M (2010). Older age, lower CD4 nadir, NNRTI uses predict slow CD4 recovery in Athena. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco CA. | ||||
Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H (2009). Hepatology: A clinical textbook. 1st ed. Flying Publisher: Dűsseldorf, Germany. p. 467. Crossref |
||||
Mauss S, Thomas B, Juergen R, Christoph S, Heiner W (2013). Hepatology: A Clinical Textbook. 4th ed. Flying Publisher: Düsseldorf, Germany. p. 467. Crossref |
||||
MOH (2008). Guidelines for management of opportunistic infections in adults and adolescents in Ethiopia. Federal HAPCO. Available: www.who.int/hiv/pub/guidelines/ethiopia_art.pdf | ||||
Nunez M, Lana R, Mendoza J (2001). Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J. AIDS 27:426-31. Crossref |
||||
Peters MG (2007). Diagnosis and management of hepatitis B virus and HIV co-infection. Top. HIV Med. 15(5):163-166. Pubmed |
||||
Plaza Z, Aguilera A, Mena A, Vispo E, Sierra-Enguita R, Tomé S, Pedreira J, Rodriguez C, Barreiro P, del Romero J, Soriano V, Poveda E (2013). Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B. AIDS 27(14):2219-2224. Crossref |
||||
Puoti M, Airoldi M, Bruno R, Zanini B, Spinetti A, Pezzoli C, Patroni A, Castelli F, Sacchi P, Filice G, Carosi G (2002). Hepatitis B Virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev. 4:27-35. Pubmed |
||||
Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, Mauss S, Rockstroh J (2008). Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 22(12):1399-1410. Crossref |
||||
Tesga E, Mengesha B, Hanson BG (1986). Hepatitis A, B, and Delta infection in Ethiopia: a serologic survey with demographic data. Am. J. Epidemiol. 123:345-351. | ||||
UNAIDS (2013). Access to Antiretroviral therapy in Africa: Status Report on Progress towards the 2015 targets. UNAIDS, Geneva. Available: http://www.unaids.org/sites/default/files/media_asset/20131219_AccessARTAfricaStatusReportProgresstowards2015Targets_en_0.pdf. | ||||
Wilkin T (2010). What causes poor CD4-cell recovery in the setting of suppressive antiretroviral therapy? Journals Watch HIV/AIDS Clinical Care. Available from: http://www.jwatch.org/ac201004260000001/2010/04/26/what-causes-poor-cd4-cell-recovery-setting. | ||||
World Health Organization (WHO) (2006). Antiretroviral Therapy for HIV Infection in Adults and Adolescents Recommendations for Public Health Approach: 2006-Revision. WHO, Geneva. 26. | ||||
World Health Organization (WHO) (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Available: http://www.who.int/hiv/pub/guidelines/arv2013/en/index.html. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0